目前关于无塑性贫血病因病源的看法
Mehmet Ali Ucar1, Meryem Sener1, Recep Dokuyucu2
1Department of Hematology, Faculty of Medicine, Balcalı Hospital, Cukurova University, Adana 01330, Turkey.
概括
无形性贫血 (AA) 是一种罕见的骨髓衰竭. 免疫抑制疗法 (IST) 和干细胞移植 (HSCT) 的进展显著改善了这种严重疾病的结果.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
背景情况:
- 无形性贫血 (AA) 是一种罕见的骨髓衰竭综合征,其特征是泛cytopenia.
- 它呈现为急性,严重的细胞衰减,通常在年轻人中,未经治疗的死亡率高.
- 最近的治疗进展改善了患者的治疗结果.
研究的目的:
- 审查目前对无塑性贫血病因病原发生的理解.
- 讨论诊断和治疗策略的进展.
- 突出新兴疗法及其对预后的影响.
主要方法:
- 关于无塑性贫血的当前研究的文献综述.
- 分析病原性,包括免疫失调,遗传突变和环境因素.
- 对诊断标准的评估和与相关疾病的差异诊断.
主要成果:
- 通过免疫抑制疗法 (IST) 加上eltrombopag和造血干细胞移植 (HSCT) 改善了患者的治疗结果.
- 确定AA病原发生的关键因素:免疫失调,遗传突变,环境触发因素.
- 新兴的疗法,如不匹配的无血缘捐赠者 (MMUD) 移植和精准医学,显示出有前途.
结论:
- 准确的差分诊断对于有效治疗无塑性贫血至关重要.
- 新的治疗方法正在改变AA的预后和管理.
- 对遗传异常和新型治疗方法的持续研究是必不可少的.
相关概念视频
Immunodeficiency Diseases
824
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
There are three main causes of immunodeficiency...
824
Regulation of Hematopoietic Stem Cells
3.1K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.1K
Bone Marrow Sampling and Transplants
260
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
260
Cell-mediated Immune Responses
65.2K
Overview
65.2K
The Intrinsic Apoptotic Pathway
5.5K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
5.5K
Disorders of Leukocytes
707
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
707


